Eplerenone, ACE inhibition and albuminuria
Phase of Trial: Phase II
Latest Information Update: 25 May 2012
At a glance
- Drugs Eplerenone (Primary) ; Fosinopril
- Indications Diabetic nephropathies; Proteinuria
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 25 May 2012 Actual patient number 30 added as reported by ClinicalTrials.gov.
- 25 May 2012 Actual end date (July 2011) added as reported by ClinicalTrials.gov.